About FDA
Total number of correspondence responded to within the month
Dictionary: The Office of the Center Director is responsible for answering the public’s and Congress’ questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals as tracked by the AIMS system and Office of Legislation which are related to all Congressional correspondence. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, technical and document requests.
The Office of the Center Director is responsible for answering the public’s questions about the work done by FDA/CVM. This measure tracks the Office of the Center Director’s timeliness in completing referrals related to all non-Congressional correspondence. Non-Congressional letter correspondences include: public inquiries received by the Secretary, Commissioner, and Center Director regarding: general information requests, expertise of a specific subject/issue, pre and post approvals, hot topic items, and any other CVM related issues.
Information is current as of March 31, 2013.
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 25 |
| Nov 2010 | N/A | 18 |
| Dec 2010 | N/A | 13 |
| Jan 2011 | N/A | 24 |
| Feb 2011 | N/A | 24 |
| Mar 2011 | N/A | 34 |
| Apr 2011 | N/A | 20 |
| May 2011 | N/A | 21 |
| Jun 2011 | N/A | 22 |
| Jul 2011 | N/A | 14 |
| Aug 2011 | N/A | 22 |
| Sep 2011 | N/A | 27 |
FY 2011 Total: 264
Number of Congressional correspondence and information or briefing requests responded to within the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 14 |
| Nov 2010 | N/A | 8 |
| Dec 2010 | N/A | 3 |
| Jan 2011 | N/A | 9 |
| Feb 2011 | N/A | 11 |
| Mar 2011 | N/A | 11 |
| Apr 2011 | N/A | 12 |
| May 2011 | N/A | 7 |
| Jun 2011 | N/A | 13 |
| Jul 2011 | N/A | 6 |
| Aug 2011 | N/A | 9 |
| Sep 2011 | N/A | 9 |
FY 2011 Total: 112
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







